Evidence map›Paper›PMID 41394883›Full record

ArticleBehavioural neurology2025

Brivaracetam Combined With Topiramate at Low Doses Alleviates Neurobehavioral Deficits and Oxidative Stress in a Chemoconvulsant Kindled Seizure Model.

Khaled Ahmed Saghir, Waseem Ashraf, Rana Muhammad Zahid Mushtaq, Faleh Alqahtani, Imran Imran

Abstract read
In one paragraph

Article in Behavioural neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Khaled Ahmed SaghirDepartment of Pharmacology, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan, bzu.edu.pk.
Waseem AshrafDepartment of Pharmacology, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan, bzu.edu.pk.ORCID https://orcid.org/0000-0003-2295-6049
Rana Muhammad Zahid MushtaqInstitute for Regeneration and Repair, Edinburgh Medical School, The University of Edinburgh, Edinburgh, UK, ed.ac.uk.
Faleh AlqahtaniDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia, ksu.edu.sa.ORCID https://orcid.org/0000-0003-3924-593X
Imran ImranDepartment of Pharmacology, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan, bzu.edu.pk.ORCID https://orcid.org/0000-0003-1337-8574

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epilepsy is a long-lasting neurological condition often associated with cognitive and behavioral comorbidities, such as anxiety, depression, and memory deficits. This study examined the therapeutic effect of topiramate (TPM) and brivaracetam (BRV), both separately and combined, using pentylenetetrazole-kindled mice. Seizure severity was visually observed during the kindling process. After that, mice underwent a series of behavioral tests to evaluate anxiety, depression, and memory performance. Subsequently, neurochemical analyses were performed to assess cholinergic activity and oxidative stress markers. The TPM + BRV group showed significantly attenuated seizure progression during all PTZ doses (

Indexed as

AnticonvulsantsOxidative StressPyrrolidinonesSeizuresTopiramateAnimalsAnxietyBehavior, AnimalDepressionDisease Models, AnimalDrug Therapy, CombinationEpilepsyKindling, NeurologicMaleMicePentylenetetrazoleAnticonvulsantsbrivaracetamPentylenetetrazolePyrrolidinonesTopiramatebrivaracetamcognitive impairmentdepressive-like behaviorepilepsyoxidative stressPTZ kindlingtopiramate

Identifiers

PMID41394883
PMCPMC12698180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.